Search

Search Constraints

You searched for: Author/Creator Arnedos, Monica

Search Results

1. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial). (November 2021)

2. Characteristics of the Metastatic Breast Cancer Population with PIK3CA Mutation in the Randomized Phase II Study SAFIR02 Breast (UCBG-0105/1304). (November 2017)

3. Concordance between HER‐2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patients. Issue 9 (5th August 2016)

4. Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door. (March 2018)

5. Influence of tumour burden on trastuzumab pharmacokinetics in HER2 positive non‐metastatic breast cancer. (7th March 2016)

6. Loco‐regional Control After Neo‐adjuvant Chemotherapy and Conservative Treatment for Locally Advanced Breast Cancer Patients. Issue 4 (2nd June 2014)

7. Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program. (January 2021)

8. Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation. (December 2021)

9. The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic. (October 2016)